These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16227146)

  • 21. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis.
    Theuns DA; Thornton AS; Klootwijk AP; Scholten MF; Vantrimpont PJ; Balk AH; Jordaens LJ
    Eur J Heart Fail; 2005 Oct; 7(6):1027-32. PubMed ID: 16109500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT.
    Cleland JG; Coletta AP; Yassin A; Buga L; Torabi A; Clark AL
    Eur J Heart Fail; 2009 Dec; 11(12):1214-9. PubMed ID: 19926603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic analysis of a randomized trial of biventricular pacing in Canada.
    Bentkover JD; Dorian P; Thibault B; Gardner M
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of Patients with Advanced Heart Failure Who Receive Device-Based Therapy for Primary Prevention of Sudden Cardiac Death: Insights from the Israeli ICD Registry.
    Suleiman M; Goldenberg I; Samniah N; Rosso R; Marai I; Pekar A; Khalameizer V; Militianu A; Glikson M
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):738-45. PubMed ID: 25754272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure.
    Pellicori P; Clark AL
    Eur J Heart Fail; 2015 Sep; 17(9):979-83. PubMed ID: 26289928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
    Chen S; Yin Y; Krucoff MW
    Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study.
    Cleland JG; Coletta AP; Clark AL
    Eur J Heart Fail; 2006 Oct; 8(6):658-61. PubMed ID: 17045839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic heart failure and sudden death: the message of CIBIS-III].
    Dequarti MC; Poggio L; Vanoli E
    Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
    Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
    J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.
    Cleland JG; Coletta AP; Buga L; Ahmed D; Clark AL
    Eur J Heart Fail; 2010 Jun; 12(6):623-9. PubMed ID: 20498271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".
    Willenheimer R; Krum H; van Veldhuisen DJ; Funck-Brentano C; Erdmann E; Meyer WR;
    Eur J Heart Fail; 2006 Mar; 8(2):219-20. PubMed ID: 16488368
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
    Trappe HJ
    Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.